Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Hims & Hers Health, Inc. Class A Common Stock
(NY:
HIMS
)
52.54
-5.33 (-9.21%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hims & Hers Health, Inc. Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
45
46
Next >
Why Hims & Hers Stock Slipped Today
October 03, 2025
Investors generally aren't fond of C-suite changes in relatively young businesses.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
October 03, 2025
Via
Benzinga
HIMS & HERS HEALTH INC (NYSE:HIMS) Shows High-Growth Momentum and Technical Breakout Potential
October 03, 2025
Hims & Hers (HIMS) is a high-growth momentum stock with strong earnings and a positive technical breakout setup, offering a compelling opportunity for investors.
Via
Chartmill
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know
October 02, 2025
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations.
Via
StockStory
Topics
World Trade
How Is The Market Feeling About Hims & Hers Health?
September 18, 2025
Via
Benzinga
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment
October 01, 2025
Via
Benzinga
The Secret to Finding the Next Amazon Is Hiding in Plain Sight
October 01, 2025
These innovators are disrupting massive industries with a customer-centric business strategy.
Via
The Motley Fool
Topics
Retirement
Eli Lilly Stock Jumps As Trump’s Drug Price Crackdown Spurs Sector Rally; Analysts Say Pfizer Deal Sets Template For Big Pharma
September 30, 2025
Via
Stocktwits
Topics
Government
Six Stocks That Shocked Wall Street: Unpacking This Year's Surprise Market Winners
September 29, 2025
The year 2025 has unfolded with a compelling narrative of unexpected triumphs in the stock market, where several companies have defied conventional wisdom and analyst forecasts to emerge as significant...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Not Nearly Enough People Are Talking About Chewy Stock
September 28, 2025
The company has multiple trends working in its favor.
Via
The Motley Fool
Topics
Artificial Intelligence
3 Healthcare Stocks Using AI to Drive Growth
September 27, 2025
AI is reshaping healthcare by improving outcomes and easing burnout. See how three companies are leading this transformation
Via
MarketBeat
Topics
Artificial Intelligence
Hims & Hers Powers YieldMax's Latest Options-Based Income ETF
September 26, 2025
YieldMax ETFs grew its expanding lineup of income-oriented funds on Tuesday with the introduction of the YieldMax HIMS Option Income Strategy ETF (NYSE: HIYY).
Via
Benzinga
Topics
ETFs
A Healthcare Debate: Progyny vs. Hims & Hers
September 26, 2025
Motley Fool analysts take a look.
Via
The Motley Fool
1 Momentum Stock with Competitive Advantages and 2 We Find Risky
September 26, 2025
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or...
Via
StockStory
2 Volatile Stocks Worth Investigating and 1 That Underwhelm
September 25, 2025
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced...
Via
StockStory
I'm Downgrading Hims & Hers Stock
September 24, 2025
The fast-growing company is taking investors on a roller-coaster ride.
Via
The Motley Fool
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today
September 23, 2025
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 2% in the morning session after an insider filed to sell a substantial block of shares.
Via
StockStory
Nvidia Just Got Another Tailwind -- Why Groq's $6.9 Billion Valuation Proves AI Chips Are Still Hot
September 23, 2025
Nvidia's unquestioned scale and ecosystem make it a clear winner.
Via
The Motley Fool
Topics
Artificial Intelligence
Supply Chain
3 Big Short Interest Names with Bullish Setups
September 22, 2025
HIMS, DLO, and TEM combine high short interest with bullish chart setups, creating strong breakout potential as market momentum stays hot.
Via
MarketBeat
Topics
Artificial Intelligence
Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy
September 21, 2025
Hims & Hers Health posted 73% revenue growth and 31% more subscribers in Q2. With analyst targets hitting $68, is now the time to buy HIMS?
Via
MarketBeat
Topics
Economy
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why
September 19, 2025
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 3.5% in the morning session after investors focused on the company's strong growth prospects, which appeared to overshadow recent...
Via
StockStory
Oscar Health Set For HIMS-Style Moonshot? Shorts Could Burn As ACA Buzz Builds
September 19, 2025
Oscar Health (OSCR) is drawing comparisons to Hims & Hers (HIMS) as short sellers may trigger a moonshot with ACA subsidies and a potential government shutdown.
Via
Benzinga
The Weight-Loss Craze Boosted The $186 Billion Telehealth Industry. What It Means For Investors.
September 19, 2025
Telehealth companies are getting a fresh infusion of business thanks to obesity drugs. Find out which stocks are benefiting.
Via
Investor's Business Daily
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs
September 18, 2025
The FDA's warnings to Eli Lilly, Novo Nordisk and Hims & Hers spotlight risks for ETFs tied to the weight-loss drug boom.
Via
Benzinga
Topics
ETFs
Hims & Hers Health's Options Frenzy: What You Need to Know
September 17, 2025
Via
Benzinga
2 High-Yield Dividend Stocks You'll Wish You Had Bought 10 Years From Now
September 17, 2025
These dividend payers cranked up their payouts over the past decade, and they could do it again.
Via
The Motley Fool
Wall Street Waits on the Fed, but Steel and Semaglutide Steal the Show
September 17, 2025
US markets closed slightly lower on Tuesday as investors waited for the Fed’s rate decision. Strong retail sales weren’t enough to lift the market, while several standout stock moves, from Steel...
Via
Chartmill
Topics
Economy
It's a Small World: 3 Stocks Leading the Sudden Rebound in Small Caps
September 16, 2025
A new market leader has snuck into town over the past month as Small Caps have pushed to the top of the leader board. Whether the trend lasts, or not, will depend a lot on what the Fed does, but one...
Via
The Motley Fool
Topics
Economy
Stocks
Hims & Hers Health (HIMS) Stock Trades Down, Here Is Why
September 16, 2025
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.5% in the afternoon session after the U.S. Food and Drug Administration (FDA) sent the company a warning letter regarding “false or...
Via
StockStory
BigBear.ai, Tesla, Hims & Hers, Rocket Lab, Warner Bros Discovery: Stocks Making The Biggest Moves Today
September 16, 2025
Via
Stocktwits
< Previous
1
2
3
4
5
6
7
8
9
...
45
46
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.